PLIN2 and metabolic dysfunction-associated steatotic liver disease: We aim to investigate the potential role of PLIN2 in the etiopathogenesis of NAFLD and, crucially, to assess the feasibility of using circulating PLIN2 levels as a novel biomarker for NAFLD diagnosis.